Marker Therapeutics is trading 5.25% up at $1.46, with no new company-specific announcement identified to explain the August 24, 2026 move.
- It closed 13.93% higher at $1.39 on August 21, 2026, continuing a volatile multi-session advance.
- Recent momentum may reflect H.C. Wainwright’s reiterated Buy rating and $10.00 price target.
- Fresh analysis highlighted cash-runway and dilution risks; neither source explicitly links those items to today’s gain.